Expiration date: 06/2022
The composition and form of issue:
Lozenges 1 tablet contains:
antibodies to prostatespecific antigen affinity purified (introduced in the form of a water-alcohol mixture of the active form of the active substance)1 0,003 g
1 the Active form of the active substance, the active form content of not more than 10?15 ng/g of active substance
excipients: lactose MCC magnesium stearate
in a contour acheikova packing 20 PCs. in cardboard pack 1, 2 or 5 packs.
Description pharmaceutical form:
Tablets from white to almost white color, valium forms, with valium and chamfer. On the flat side with the mark affixed MATERIA MEDICA, on the other flat side of AFALA.
Description pharmacological action:
Reduces the phenomena of swelling and inflammation in the prostate, normalizes its functional state. Improves urodynamics reduces the volume of residual urine, normalizes the tone of the lower urinary tract, reduces dizuricheskih disorders.
- benign prostatic hyperplasia stage I and II
- in the complex therapy of acute and chronic prostatitis (as an anti-inflammatory and analgesic)
- dysuric disorders (frequent urge to urination, including night, difficulty in urination, pain or discomfort in the crotch area), including accompanying benign prostatic hyperplasia stage I and II and acute and chronic prostatitis.
- Increased individual sensitivity to product components.
When using the drug on these indications and dosages of these side effects were not identified.
No incompatibilities with other drugs to date is not registered.
Method of application and dose:
Inside, 2 table. at the reception (to keep the tablet in mouth until fully dissolved) is not during a meal. The drug should be taken twice a day, morning and evening (before and after sleep). The recommended duration of reception of preparation — 16 weeks.
When expressed pain syndrome and dysuric disorders in the first 2-3 weeks of treatment shows taking the drug up to 4 times per day.
If necessary, the physician may be repeated course of treatment is 1-4 months.
In case of accidental overdose dyspepsia caused by members of the drug fillers.
The preparation includes lactose, and therefore it is not recommended to appoint patients with congenital galactosemia, syndrome of malabsorption of glucose or galactose, or congenital lactase deficiency.
The effect of the drug on the ability to drive vehicles or work with other potentially dangerous machinery. Not affected.